Skip to main content
Top
Published in: Familial Cancer 1/2015

01-03-2015 | Short Communication

Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome

Authors: Kirsty Mann, Jill Magee, Marine Guillaud-Bataille, Christophe Blondel, Brigitte Bressac-de Paillerets, Josie Yeatman, Ingrid Winship

Published in: Familial Cancer | Issue 1/2015

Login to get access

Abstract

Medulloblastoma tumours may arise sporadically or as part of an inherited syndrome. A subset of children with medulloblastoma carry germline and somatic mutations in the SUFU tumour suppressor gene located at 10q24. We report a 55 year old woman referred for investigation on the basis of skin lesions and a family history of two children from different unions with medulloblastoma. Examination of our patient revealed facial papules (classified as benign folliculosebaceous hamartomatous lesions) and dysmorphology (macrocephaly, hypertelorism and prognathism). She reported her father and her son share the same dermatological features; photographs of the son display hypertelorism. Sequencing in our patient revealed a splice-site mutation in intron 6 of SUFU (c. 756+1G>A), predicted to lead to skipping of exon 6. We suggest that the emerging phenotype in SUFU associated with familial medulloblastoma may include hamartomatous skin lesions. Consideration of these features, along with macrocephaly will alert clinicians to the likely genetic basis of the syndrome, affording the opportunity for genetic counselling, prenatal or pre-implantation genetic diagnosis in at-risk families.
Literature
1.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedCentralPubMed Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedCentralPubMed
2.
go back to reference Ng D, Stavrou T, Liu L, Taylor MD, Gold B, Dean M, Kelley MJ, Dubovsky EC, Vezina G, Nicholson HS, Byrne J, Rutka JT, Hogg D, Reaman GH, Goldstein AM (2005) Retrospective family study of childhood medulloblastoma. Am J Med Genet A 134:399–403CrossRefPubMed Ng D, Stavrou T, Liu L, Taylor MD, Gold B, Dean M, Kelley MJ, Dubovsky EC, Vezina G, Nicholson HS, Byrne J, Rutka JT, Hogg D, Reaman GH, Goldstein AM (2005) Retrospective family study of childhood medulloblastoma. Am J Med Genet A 134:399–403CrossRefPubMed
3.
go back to reference Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64(5):959–961 (review)CrossRefPubMedCentralPubMed Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64(5):959–961 (review)CrossRefPubMedCentralPubMed
4.
go back to reference Slade I, Murray A, Hanks S, Kumar A, Walker L, Hargrave D, Douglas J, Stiller C, Izatt L, Rahman N (2011) Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer 10:337–342CrossRefPubMed Slade I, Murray A, Hanks S, Kumar A, Walker L, Hargrave D, Douglas J, Stiller C, Izatt L, Rahman N (2011) Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer 10:337–342CrossRefPubMed
5.
go back to reference Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT, Hogg D (2002) Mutations in SUFU predispose to medulloblastoma. Nat Genet 31:306–310CrossRefPubMed Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT, Hogg D (2002) Mutations in SUFU predispose to medulloblastoma. Nat Genet 31:306–310CrossRefPubMed
6.
go back to reference Brugières L, Remenieras A, Pierron G, Varlet P, Forget S, Byrde V, Bombled J, Puget S, Caron O, Dufour C, Delattre O, Bressac-de Paillerets B, Grill J (2012) High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol 30:2087–2093CrossRefPubMed Brugières L, Remenieras A, Pierron G, Varlet P, Forget S, Byrde V, Bombled J, Puget S, Caron O, Dufour C, Delattre O, Bressac-de Paillerets B, Grill J (2012) High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol 30:2087–2093CrossRefPubMed
7.
go back to reference Li ZJ, Nieuwenhuis E, Nien W, Zhang X, Zhang J, Puviindran V, Wainwright BJ, Kim PC, Hui CC (2012) Kif7 regulates Gli2 through SUFU-dependent and -independent functions during skin development and tumorigenesis. Development 139:4152–4161CrossRefPubMed Li ZJ, Nieuwenhuis E, Nien W, Zhang X, Zhang J, Puviindran V, Wainwright BJ, Kim PC, Hui CC (2012) Kif7 regulates Gli2 through SUFU-dependent and -independent functions during skin development and tumorigenesis. Development 139:4152–4161CrossRefPubMed
8.
go back to reference Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T, McKinnon PJ (2007) Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26:6442–6447CrossRefPubMed Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T, McKinnon PJ (2007) Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26:6442–6447CrossRefPubMed
9.
go back to reference Heby-Henricson K, Bergström A, Rozell B, Toftgård R, Teglund S (2012) Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in SUFU heterozygous mutant mice. Mol Carcinog 51(9):754–760CrossRefPubMedCentralPubMed Heby-Henricson K, Bergström A, Rozell B, Toftgård R, Teglund S (2012) Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in SUFU heterozygous mutant mice. Mol Carcinog 51(9):754–760CrossRefPubMedCentralPubMed
10.
go back to reference Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, Cusano R, Marzocchi C, Garrè ML, Clementi M, Scarrà GB (2009) Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 149A(7):1539–1543CrossRefPubMed Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, Cusano R, Marzocchi C, Garrè ML, Clementi M, Scarrà GB (2009) Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 149A(7):1539–1543CrossRefPubMed
11.
go back to reference Brugières L, Pierron G, Chompret A, Paillerets BB, Di Rocco F, Varlet P, Pierre-Kahn A, Caron O, Grill J, Delattre O (2010) Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet 47:142–144CrossRefPubMed Brugières L, Pierron G, Chompret A, Paillerets BB, Di Rocco F, Varlet P, Pierre-Kahn A, Caron O, Grill J, Delattre O (2010) Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet 47:142–144CrossRefPubMed
12.
go back to reference Aavikko M, Li SP, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E, Li Y, Vesanen K, Smith MJ, Evans DG, Pöyhönen M, Kiuru A, Auvinen A, Aaltonen LA, Taipale J, Vahteristo P (2012) Loss of SUFU function in familial multiple meningioma. Am J Hum Genet 91(3):520–526CrossRefPubMedCentralPubMed Aavikko M, Li SP, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E, Li Y, Vesanen K, Smith MJ, Evans DG, Pöyhönen M, Kiuru A, Auvinen A, Aaltonen LA, Taipale J, Vahteristo P (2012) Loss of SUFU function in familial multiple meningioma. Am J Hum Genet 91(3):520–526CrossRefPubMedCentralPubMed
13.
go back to reference Kijima C, Miyashita T, Suzuki M, Oka M, Fujii K (2012) Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Fam Cancer 11:565–570CrossRefPubMed Kijima C, Miyashita T, Suzuki M, Oka M, Fujii K (2012) Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Fam Cancer 11:565–570CrossRefPubMed
14.
go back to reference Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML (1999) Birt–Hogg–Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 135:1195–1202PubMed Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML (1999) Birt–Hogg–Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 135:1195–1202PubMed
15.
go back to reference Winship IM, Dudding TE (2008) Lessons from the skin—cutaneous features of familial cancer. Lancet Oncol 9:462–472 (review)CrossRefPubMed Winship IM, Dudding TE (2008) Lessons from the skin—cutaneous features of familial cancer. Lancet Oncol 9:462–472 (review)CrossRefPubMed
Metadata
Title
Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome
Authors
Kirsty Mann
Jill Magee
Marine Guillaud-Bataille
Christophe Blondel
Brigitte Bressac-de Paillerets
Josie Yeatman
Ingrid Winship
Publication date
01-03-2015
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2015
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9752-1

Other articles of this Issue 1/2015

Familial Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine